Bambusa Therapeutics Inc. (BBTX) Stock Ticker
BBTX right now
Market factors today
Unlock the full BBTX picture
About Bambusa Therapeutics Inc.
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
BBTX stock facts
| Ticker symbol | BBTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $697.7M |
| Headquarters | Boston, MA, US |
| IPO date | 2026-10-30 |
| Website | www.bambusatx.com |
What you can see for BBTX on Tickr
Live BBTX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the BBTX report.
Rankings
FAQ
What is the ticker symbol for Bambusa Therapeutics Inc.?
The ticker symbol for Bambusa Therapeutics Inc. is BBTX, listed on the NASDAQ.
What is BBTX?
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.